Core Viewpoint - The company is optimistic about the recombinant collagen market, highlighting its advantages in safety, efficacy, and sustainability, which are seen as fundamental drivers for industry development [1] Group 1: Industry Insights - Recombinant collagen production occurs in controlled fermentation environments, mitigating risks associated with animal-derived collagen, such as viral transmission and allergic reactions [1] - The technology allows for precise production of recombinant collagen with specific amino acid sequences, enhancing targeted efficacy for various applications, including anti-wrinkle and tissue regeneration [1] - The fermentation process offers scalability and consistency, enabling low-cost, high-quality production, thus overcoming limitations faced by animal-derived collagen [1] Group 2: Company Performance - The company operates six brands centered around recombinant collagen, with key brands contributing over 95% of revenue; projected revenues for 2024 are 4.54 billion and 840 million for the two main brands, with compound annual growth rates of 73.4% and 11.8% respectively from 2021 to 2024 [2] - The company is facing short-term operational pressures due to market discussions surrounding the content and testing methods of recombinant collagen, impacting brand performance, particularly for its flagship product [2] - The company is shifting from reliance on a single product to a strategy of "multiple brands, multiple categories, and multiple channels" to address challenges [2] Group 3: Product Development and Market Strategy - Plans for 2026 include launching a medical device and five skincare lines, with marketing efforts focused on core products [3] - The company aims to enhance its brand presence through collaborations and expanding its retail footprint, including increasing coverage in approximately 150,000 pharmacies nationwide [3] - The medical aesthetics sector is identified as a strategic growth area, with plans to establish a dedicated division and expand into around 2,000 medical aesthetic institutions by 2026 [3] Group 4: Financial Projections - The company is rated "outperform" with a target price of 43.6 HKD, indicating a potential upside of 22.0%; revenue projections for 2025-2027 are 5.49 billion, 5.99 billion, and 6.69 billion respectively, with expected growth rates of -0.9%, 9.1%, and 11.8% [4] - Gross margins are projected to remain stable at around 80.5% to 79.2% from 2025 to 2027, while net profit margins are expected to decline slightly [4]

Core Viewpoint - The report from CITIC Securities indicates a gradual recovery in high-end consumption in China since Q3 2025, driven by the wealth effect from rising stock markets, with positive signs from international luxury brands and high-end retail properties [1] Group 1: Recovery Indicators - International luxury brands have shown signs of recovery since Q2 2025, with revenue growth returning in the Asia-Pacific region by Q3 2025 [2] - High-end retail properties in China began to recover at the end of 2024 and early 2025, with improved occupancy rates and sales, particularly in top luxury malls [2] - The global luxury market also entered a recovery phase starting Q3 2025 [2] Group 2: Investment Opportunities in High-End Consumption - The recovery of high-end consumption is influenced by factors such as the proportion of VIC (Very Important Customer) groups, the sequence of consumption based on wealth increase, the elasticity of supply, and consumption trends [3] - Categories with strong initial demand, driven by social status and identity needs, are expected to recover first, while categories with a high proportion of VIC customers and good supply conditions will show more sustained growth [3] - The fastest-growing segments in the luxury market from 2019 to 2025 include luxury cruises, private jets, high-end dining, personal luxury goods, luxury hotels, and high-end home goods [3] Group 3: Recommended Investment Targets - The report recommends focusing on luxury jewelry and leather goods, high-end domestic beauty products, and high-end outdoor sports [4] - Specific companies to watch include gold and jewelry brands like Lao Pu Gold and Chow Tai Fook, beauty brands like Mao Ge Ping, and sportswear brands like Anta Sports [4] - Other areas of interest include high-end commercial real estate, high-end residential real estate, gaming, private aviation, high-end tourism and dining, and premium liquor [4]

Core Insights - The approval of the botulinum toxin product by Aimeike enhances the company's aesthetic medicine product line, filling a gap in its offerings [1] - The combination of this new product with existing offerings allows the company to provide more comprehensive solutions to customers, thereby strengthening its core competitiveness [1] - The aesthetic medicine consumption penetration rate still has significant room for growth, indicating potential for future expansion [1] Product Development - Aimeike has several products in development, including those for weight management and submental fat, which will further enrich its aesthetic medicine product pipeline upon launch [1] - The company is investing in self-research to create new product lines while also pursuing external acquisitions to enhance its product offerings [1] Financial Projections - The forecast for the company's net profit attributable to shareholders for 2025-2027 is set at 1.564 billion, 1.794 billion, and 2.099 billion yuan, respectively [1] - Corresponding price-to-earnings ratios (PE) are projected to be 28.2, 24.6, and 21 times for the same period [1] - The company maintains an "outperform the market" rating based on these projections [1]

Group 1 - The report maintains a positive outlook on the beauty and personal care industry, highlighting the ongoing trend of domestic substitution and the emergence of high-quality domestic brands [1][5] - The beauty and personal care sector is expected to continue its growth trajectory, driven by strong brand marketing, product matrix, channel strategies, and management strategies [5][27] - The report identifies key investment opportunities in leading domestic brands such as Mao Ge Ping, Marubi, Proya, and RuYuchen, which are expected to maintain strong growth due to their competitive advantages [5][27] Group 2 - In 2025, the beauty and personal care sector showed stable revenue performance, with a slight increase in profit growth compared to revenue growth [17][22] - The overall performance of the beauty sector in 2025 was moderate, with a year-on-year revenue increase of 3.1% and a net profit increase of 5.0% [17][22] - The cosmetics market in 2025 experienced a steady retail growth rate, with a year-on-year increase of 4.8% in retail sales for cosmetics in China [22][27] Group 3 - The report notes a significant shift in consumer preferences towards efficacy-driven skincare products, with a growing focus on product ingredients and effectiveness [53][57] - The luxury segment of the beauty market is experiencing robust growth, particularly during promotional events, with high-end brands leading the sales increase [63][64] - The report highlights the transformation of sales channels, with Tmall focusing on high-end beauty products while Douyin showcases the rise of domestic brands [30][28] Group 4 - The medical aesthetics market is projected to maintain a compound annual growth rate (CAGR) of around 10% from 2025 to 2028, despite a slowdown in overall growth [31][38] - High-end consumers are increasingly seeking anti-aging treatments, with a notable rise in spending among this demographic [41][39] - The medical aesthetics industry is undergoing a consolidation phase, driven by stricter regulations and a slowdown in the growth of medical institutions [42][43] Group 5 - The personal care market is seeing strong growth in body care products, with a market share of 56% for body care and 44% for hair care [47][45] - The primary consumer demographic for personal care products is women aged 21-35, indicating a growing emphasis on personal care among younger consumers [48][49] - The report emphasizes the importance of product efficacy, with consumers increasingly prioritizing moisturizing, oil control, and beauty-enhancing benefits in personal care products [48][50]

Macro and Strategy - The global commodity market has entered a structural uptrend since the end of 2025, with industrial and precious metals leading the rise, driven by geopolitical uncertainties and a shift in global economic structure [7][8] - The demand for computing power is driving a divergence in commodity prices, with significant increases in copper and oil ratios indicating a new economic growth model centered around "computing power + electricity" [7][8] - The macroeconomic indicators show a recovery in China's economy, with December's manufacturing PMI returning above the expansion threshold, indicating effective policy support [10][11] Industry and Company - The AIDC power equipment sector is expected to benefit from the surge in data center construction, with major tech companies accelerating their investments in AI data centers [26][27] - The solid-state battery industry is experiencing rapid industrialization, with significant improvements in profitability expected for lithium battery companies in 2026 due to ongoing demand for energy storage [26][30] - The global energy storage demand is projected to reach 404 GWh in 2026, a year-on-year increase of 38%, driven by market demand and supportive government policies [28] - Wind power equipment manufacturers are expected to see improved profitability in 2026, with domestic installations projected to grow by 10%-20% [28] - The electric grid equipment sector is anticipated to experience increased demand, particularly with the acceleration of ultra-high voltage approvals and the introduction of new smart meter standards [29]

Group 1 - The core viewpoint presented by the chief economist of Dongwu Securities, Lu Zhe, is that consumer spending does not require stimulation as people will spend money when they have it, which is a reflection of human nature [1] - Lu Zhe emphasizes the importance of the middle and low-income groups in consumer structure, noting that while they are significant, their impact is a slow variable [1] - He critiques the current approach of universal cash vouchers for consumption stimulation, suggesting that it is not realistic in the current environment, and points out the issue of "eating old capital" in current product subsidies [1] Group 2 - In the context of the 2025 automotive market, Lu Zhe highlights that strong growth in car consumption was largely driven by consumer expectations of the end of subsidies, leading to a pull-forward of demand from 2027 [3] - He warns of the risks associated with this demand drop-off and suggests that the government should gradually reduce consumption subsidies in 2026 compared to 2025 to avoid future issues [3] - Lu Zhe identifies sustainable consumption in service sectors, such as medical beauty, fitness, domestic services, and pet economy, as a key area for future growth and subsidy effectiveness [3]

Core Viewpoint - The light industry and beauty care sector is expected to stabilize and improve by 2026, driven by domestic demand policies and steady export growth, despite facing certain pressures in the broader environment [2] Domestic Demand - The "14th Five-Year Plan" year is anticipated to see an increase in domestic demand policies, coupled with a growing consumer pursuit of high-quality living, which opens up significant growth opportunities for the industry [2][3] Export Potential - The cross-border e-commerce penetration rate has substantial room for improvement, and the improvement of international relations along with the demand boost from emerging markets will further expand the market, injecting momentum into the industry's overseas expansion [2][3] Company Insights - Companies with core technology and brand advantages are expected to seize opportunities, with cutting-edge technology enhancing product competitiveness and brand strength breaking the price-performance competition [2] - These companies are likely to benefit from domestic demand and explore overseas markets through global layouts, leading the growth in the trend of high-quality industry development [2] Investment Focus - **Beauty Sector**: Focus on high-end skincare and makeup brands with Eastern cultural characteristics such as Maogeping (01318) and Lin Qingxuan (02657), as well as companies like Marubi Biotechnology (603983.SH) showing marginal improvements [3] - **Home Furnishing**: Attention on leading companies with strong channel capabilities and multi-category layouts like Oppein Home Group (603833.SH) and Kuka Home (603816.SH), as well as Man Wah Holdings (01999) benefiting from the anticipated recovery in the US real estate market due to Federal Reserve rate cuts [3] - **Two-Wheel & Motorcycle**: The two-wheeler market is generally stable with a natural replacement cycle, and companies like Yadea Technology (01585), Aima Technology (603529.SH), and Ninebot (689009.SH) are under focus as market expectations are currently pessimistic [3] Light Industry Consumption - **Personal Care**: Companies with a big product strategy and all-channel expansion capabilities such as Baiya Co., Ltd. (003006.SZ) and Weigao Medical (300888.SZ) are noteworthy [4] - **Stationery**: Product and channel optimization are key for stationery companies adapting to current consumer trends, with attention on Morning Glory (603899.SH) and Qixin Group (002301.SZ) [4] Jewelry Sector - Focus on Laopu Gold (06181), which is expected to see performance growth due to continuous channel expansion and market breakthroughs [5] Export Companies - Companies with significant technical barriers and brand advantages in high-demand segments such as Haoyang Co., Ltd. (300833.SZ) and Yiyi Co., Ltd. (001206.SZ) are of interest [5]

Investment Rating - The report indicates that the cosmetics and medical beauty sector is currently underperforming compared to the market, with the Shenwan Beauty Care Index rising by 2.6% from December 31, 2025, to January 9, 2026, which is lower than the overall market performance [1][2]. Core Insights - 毛戈平 has initiated an international strategic partnership with L Catterton, a leading global consumer investment firm, focusing on global market expansion, acquisitions, strategic investments, capital structure optimization, and talent introduction [1][6][17]. - The approval of products such as 爱美客's botulinum toxin and 奇璞生物's collagen implant signifies ongoing advancements in the medical beauty supply chain, enhancing competitive diversity for 2026 [1][6][18][19]. - The report highlights the robust foundation of 壹网壹创's e-commerce operations, leveraging AI to enhance performance and expand its market reach, particularly in the consumer goods sector [1][7][8][10]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with specific indices underperforming against the Shenwan A Index [2][4]. - The top-performing stocks in the sector include 力合科创 (+14.7%), 毛戈平 (+8.6%), and 水羊股份 (+7.6%), while the underperformers include 嘉亨家化 (-3.9%) and 百亚股份 (-2.8%) [2][5]. Recent Developments - 毛戈平's strategic collaboration with L Catterton aims to enhance its brand's presence in high-end retail channels globally and establish a joint investment fund focused on premium beauty products [1][6][17]. - The approval of 爱美客's botulinum toxin and 奇璞生物's collagen implant reflects a significant push in the medical beauty equipment supply chain, contributing to competitive advantages in the upcoming year [1][6][18][19]. E-commerce Insights - 壹网壹创's e-commerce operations are well-established, with a comprehensive coverage of consumer goods categories and a strong partnership with Alibaba, which is expected to drive revenue growth through AI integration [1][7][8][10]. - The e-commerce sector is witnessing a resurgence in attention, with Alibaba's platform traffic rebounding, indicating a potential recovery in the performance of e-commerce operations [1][8][10]. Market Data - The report notes that the retail sales of cosmetics in China for November 2025 grew by 6.1%, supported by promotional events like Double 11, indicating a robust recovery in consumer spending [13][15]. - The overall retail sales of consumer goods in China reached 45.6 trillion yuan in the first eleven months of 2025, with a year-on-year growth of 4.0% [13][15].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, despite recent underperformance compared to the market [2][3]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance than the market, with the Shenwan Beauty Care Index rising by 2.6% from December 31, 2025, to January 9, 2026, which is lower than the Shenwan A Index by 2.8 percentage points [3][4]. - 毛戈平 has initiated an international strategic partnership with L Catterton, focusing on global market expansion, acquisitions, and strategic investments, which is expected to enhance its high-end retail channels and operational optimization [9][21]. - Recent approvals for products such as 爱美客's botulinum toxin and 奇璞生物's collagen implant highlight the ongoing advancements in the medical beauty supply chain, supporting diversified competition in 2026 [9][22][23]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has underperformed the market, with specific indices showing lower growth rates compared to the overall market [3][4]. - The top-performing stocks in the sector include 力合科创 (+14.7%), 毛戈平 (+8.6%), and 水羊股份 (+7.6%), while the worst performers were 嘉亨家化 (-3.9%) and 百亚股份 (-2.8%) [5]. Recent Developments - 毛戈平's strategic partnership with L Catterton aims to enhance its brand's global presence and operational capabilities [9][21]. - The approval of 爱美客's botulinum toxin and 奇璞生物's collagen implant signifies a robust supply chain in the medical beauty sector [22][23]. Investment Recommendations - Recommended companies include 毛戈平, 上美股份, and 上海家化 for their strong brand matrices and growth potential. Companies like 爱美客 and 朗姿股份 are highlighted for their strong profitability and product pipeline [3][10]. - The report suggests focusing on companies with high R&D barriers and strong profitability in the upstream medical beauty segment [3][10].

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the successful IPO of Shaanxi Tourism, which leverages its rich tourism resources and strong operational experience to build competitive advantages through a combination of performance-driven tourism, cable car operations, and dining services [22][24][34] - The report emphasizes the resilience of the cultural tourism industry amid ongoing trends to expand domestic demand and promote consumption, suggesting that Shaanxi Tourism's future growth will be supported by new performance projects and cable car capacity upgrades [36] Summary by Sections Retail and Social Services Market Review - The retail and social services indices rose by 4.23% and 4.71% respectively during the week of January 5 to January 9, 2026, with the Shanghai Composite Index increasing by 3.82% [12][14] - Among the sub-sectors, the supermarket segment showed the highest growth, with an increase of 8.18% year-to-date [15][17] Industry Dynamics: Shaanxi Tourism - Shaanxi Tourism, a leading regional tourism company, successfully listed on the Shanghai Stock Exchange on January 6, 2026, becoming the first A-share listed company of the year [22] - The company reported significant revenue contributions from its tourism performance and cable car operations, with a net profit margin and gross profit margin remaining high post-pandemic [24][27] - Revenue breakdown for the first half of 2025 shows that tourism performance accounted for 60.2%, cable car operations for 35.8%, and dining services for 4.0% [24] Investment Recommendations - The report recommends focusing on high-end gold and fashion jewelry brands, highlighting companies like Chow Tai Fook and Chao Hong Ji, which are expected to benefit from market trends [39] - It also suggests monitoring offline retail companies adapting to market changes and AI-enabled cross-border e-commerce leaders, with specific recommendations for Yonghui Supermarket and Aiying Room [39] - In the cosmetics sector, the report emphasizes brands that capture emotional value and innovate with safe ingredients, recommending companies like Mao Ge Ping and Proya [40]